ADD/ADHD News

Low-level lead poisoning remains prevalent across the United States and globally, warranting screening and identification of those at highest risk, according to a recently published review.

The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Approximately one in nine children in the United States had ever received an ADHD diagnosis as of 2022, according to research published in the Journal of Clinical Child & Adolescent Psychology.

Participation in the Pediatric Academic Societies Meeting is back to pre-COVID-19 levels of engagement, according to one of the event’s program chairs.

A new study of more than 185,000 children showed no association between acetaminophen use in pregnancy and a risk for neurodevelopmental disorders in children, including autism and ADHD, according to results published in JAMA.

A systematic review of hundreds of studies showed that medication has the best chance to improve ADHD outcomes in children and that other treatments have varied effects, according to results published in Pediatrics.

SAN DIEGO — Children with vs. without atopic dermatitis are more likely to experience learning and memory difficulties, according to a poster presented at the American Academy of Dermatology Annual Meeting.

Early-life exposure to screens and digital media was associated with higher odds of atypical sensory processing in a study of nearly 1,500 children, researchers reported in JAMA Pediatrics.